Statistical approach to COVID-19 clinical trials aims to accelerate drug approval process

(The MIT Press) MIT researchers develop analytics focused on accelerating COVID-19 therapeutics clinical trials and attracting more funding for vaccines and anti-infectives.

Source: EurekAlert! - Medicine and Health - May 19, 2020 Category: International Medicine & Public Health Source Type: news